<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Pharma Spending On Vermont Doctors Increases</title>
	<atom:link href="http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 22:26:38 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Sam</title>
		<link>http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/#comment-366300</link>
		<dc:creator>Sam</dc:creator>
		<pubDate>Fri, 11 Jul 2008 04:29:31 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14559#comment-366300</guid>
		<description>And for the psychiatric drugs listed on the NotApprovedForPediatricUse page, prescribed for ADD, ADHD, depression and other psychiatric indications, there was a 346% increase in Medicaid spending in Vermont from 2000 through 2005 of $2.3 million in 2000 to $10.5 million in 2005 (Medicare Part D kicked in in January of 2006, so the continuing trend for 2006 through 2007 - while assumed to exist - cannot be shown with the available data). This exceeds the National average increase of 304% for the same period, same drugs: http://www.psychdrugdangers.com/VT/VermontMedicaidPaymentsEx.html

Something surely influenced these sales.</description>
		<content:encoded><![CDATA[<p>And for the psychiatric drugs listed on the NotApprovedForPediatricUse page, prescribed for ADD, ADHD, depression and other psychiatric indications, there was a 346% increase in Medicaid spending in Vermont from 2000 through 2005 of $2.3 million in 2000 to $10.5 million in 2005 (Medicare Part D kicked in in January of 2006, so the continuing trend for 2006 through 2007 - while assumed to exist - cannot be shown with the available data). This exceeds the National average increase of 304% for the same period, same drugs: <a href="http://www.psychdrugdangers.com/VT/VermontMedicaidPaymentsEx.html" rel="nofollow">http://www.psychdrugdangers.com/VT/VermontMedicaidPaymentsEx.html</a></p>
<p>Something surely influenced these sales.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Sam</title>
		<link>http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/#comment-366296</link>
		<dc:creator>Sam</dc:creator>
		<pubDate>Fri, 11 Jul 2008 03:30:41 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14559#comment-366296</guid>
		<description>See http://www.psychdrugdangers.com/NotApprovedForPediatricUse.html

and pulldown the Medicaid Drug Uses and Payments which includes several reports from Vermont Medicaid for April through September of 2007. The first one in the sublist (http://www.psychdrugdangers.com/VT/MHChildren'sDrugUseSpending2-12-08.html if you want to access it direct) reports almost $10 dollars spent on children under 18 for psychiatric diagnoses (the "TX" entries) and drugs during that 6 month period.</description>
		<content:encoded><![CDATA[<p>See <a href="http://www.psychdrugdangers.com/NotApprovedForPediatricUse.html" rel="nofollow">http://www.psychdrugdangers.com/NotApprovedForPediatricUse.html</a></p>
<p>and pulldown the Medicaid Drug Uses and Payments which includes several reports from Vermont Medicaid for April through September of 2007. The first one in the sublist (http://www.psychdrugdangers.com/VT/MHChildren&#8217;sDrugUseSpending2-12-08.html if you want to access it direct) reports almost $10 dollars spent on children under 18 for psychiatric diagnoses (the &#8220;TX&#8221; entries) and drugs during that 6 month period.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Paul G</title>
		<link>http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/#comment-366294</link>
		<dc:creator>Paul G</dc:creator>
		<pubDate>Fri, 11 Jul 2008 03:05:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14559#comment-366294</guid>
		<description>The increase is because more companies reported that the last cycle...

bogus analysis trying to make a point</description>
		<content:encoded><![CDATA[<p>The increase is because more companies reported that the last cycle&#8230;</p>
<p>bogus analysis trying to make a point</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ed Silverman</title>
		<link>http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/#comment-366221</link>
		<dc:creator>Ed Silverman</dc:creator>
		<pubDate>Thu, 10 Jul 2008 13:30:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14559#comment-366221</guid>
		<description>Hi Lisa,

I've rifled through the report and I don't see a breakdown of that sort, unless I rifled too quickly. And individual names weren't mentioned, either. 

ed</description>
		<content:encoded><![CDATA[<p>Hi Lisa,</p>
<p>I&#8217;ve rifled through the report and I don&#8217;t see a breakdown of that sort, unless I rifled too quickly. And individual names weren&#8217;t mentioned, either. </p>
<p>ed</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lisa Van S</title>
		<link>http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/#comment-366220</link>
		<dc:creator>Lisa Van S</dc:creator>
		<pubDate>Thu, 10 Jul 2008 13:25:43 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14559#comment-366220</guid>
		<description>Ed,

Do we know how many of the Psychiatrists are child and adolescent specialists and if so was Dr. Fassler on the list? Important Info dont you think?</description>
		<content:encoded><![CDATA[<p>Ed,</p>
<p>Do we know how many of the Psychiatrists are child and adolescent specialists and if so was Dr. Fassler on the list? Important Info dont you think?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ed Silverman</title>
		<link>http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/#comment-366218</link>
		<dc:creator>Ed Silverman</dc:creator>
		<pubDate>Thu, 10 Jul 2008 13:14:10 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14559#comment-366218</guid>
		<description>Hi Chris,

Good question. For what it's worth, this verbiage appears on page 6 of the report:

"Just as the payments by pharmaceutical manufacturers in FY 07 has increased, so too has the number of companies filing reports with the Vermont Attorney General's Office. In FY 06, 81 companies disclosed payments made during that reporting period. In FY 05, 73 companies disclosed payments made during that reporting period. Since FY 05, filings have therefore increased by approximately 15%."

Hope that helps, a little,
ed</description>
		<content:encoded><![CDATA[<p>Hi Chris,</p>
<p>Good question. For what it&#8217;s worth, this verbiage appears on page 6 of the report:</p>
<p>&#8220;Just as the payments by pharmaceutical manufacturers in FY 07 has increased, so too has the number of companies filing reports with the Vermont Attorney General&#8217;s Office. In FY 06, 81 companies disclosed payments made during that reporting period. In FY 05, 73 companies disclosed payments made during that reporting period. Since FY 05, filings have therefore increased by approximately 15%.&#8221;</p>
<p>Hope that helps, a little,<br />
ed</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris</title>
		<link>http://www.pharmalot.com/2008/07/pharma-spending-on-vermont-doctors-increases/#comment-366211</link>
		<dc:creator>Chris</dc:creator>
		<pubDate>Thu, 10 Jul 2008 11:47:38 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14559#comment-366211</guid>
		<description>It would be interesting to know if this is an actual increase in expenditures or an increase in compliance with the reporting requirements.</description>
		<content:encoded><![CDATA[<p>It would be interesting to know if this is an actual increase in expenditures or an increase in compliance with the reporting requirements.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.158 seconds -->

